23 May 2022 , 03:16 PM
Net profit of Shree Ganesh Biotech India rose 3366.67% to Rs 1.04 crore in the quarter ended March 2022 as against Rs 0.03 crore during the previous quarter ended March 2021. Sales rose 117.49% to Rs 20.14 crore in the quarter ended March 2022 as against Rs 9.26 crore during the previous quarter ended March 2021. For the full year,net profit rose 690.63% to Rs 2.53 crore in the year ended March 2022 as against Rs 0.32 crore during the previous year ended March 2021. Sales rose 322.08% to Rs 72.64 crore in the year ended March 2022 as against Rs 17.21 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 20.14 | 9.26 | 117 | 72.64 | 17.21 | 322 |
OPM % | 5.16 | 4.54 | – | 4.75 | 4.13 | – |
PBDT | 1.04 | 0.42 | 148 | 3.50 | 0.71 | 393 |
PBT | 1.04 | 0.42 | 148 | 3.50 | 0.71 | 393 |
NP | 1.04 | 0.03 | 3367 | 2.53 | 0.32 | 691 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.